BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 10622499)

  • 1. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy.
    Sugarbaker PH; Chang D
    Ann Surg Oncol; 1999 Dec; 6(8):727-31. PubMed ID: 10622499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
    Sugarbaker PH
    Eur J Surg Oncol; 2001 Apr; 27(3):239-43. PubMed ID: 11373099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients.
    Esquivel J; Sugarbaker PH
    Ann Surg; 2001 Aug; 234(2):198-205. PubMed ID: 11505065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
    Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
    Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
    Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Chang D; Koslowe P
    Cancer Treat Res; 1996; 81():89-104. PubMed ID: 8834578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy.
    Glehen O; Mohamed F; Sugarbaker PH
    Ann Surg; 2004 Aug; 240(2):278-85. PubMed ID: 15273552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis.
    Pallas N; Karamveri C; Kyziridis D; Hristakis C; Kyriakopoulos V; Kalakonas A; Vaikos D; Tentes AK
    J BUON; 2017; 22(6):1547-1553. PubMed ID: 29332351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal Involvement Is More Common Than Nodal Involvement in Patients With High-Grade Appendix Tumors Who Are Undergoing Prophylactic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Mehta A; Mittal R; Chandrakumaran K; Carr N; Dayal S; Mohamed F; Moran B; Cecil T
    Dis Colon Rectum; 2017 Nov; 60(11):1155-1161. PubMed ID: 28991079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
    Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node metastasis in epithelial malignancies of the appendix with peritoneal dissemination does not reduce survival in patients treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    González-Moreno S; Brun E; Sugarbaker PH
    Ann Surg Oncol; 2005 Jan; 12(1):72-80. PubMed ID: 15827781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
    Pestieau SR; Sugarbaker PH
    Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis.
    Wagner PL; Jones D; Aronova A; Shia J; Weiser MR; Temple LK; Chung KY; O'Reilly EM; Kelsen D; Paty PB; Nash GM
    Dis Colon Rectum; 2012 Apr; 55(4):407-15. PubMed ID: 22426264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy.
    Sugarbaker PH; Jablonski KA
    Ann Surg; 1995 Feb; 221(2):124-32. PubMed ID: 7857141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.
    Marcotte E; Dubé P; Drolet P; Mitchell A; Frenette S; Leblanc G; Leclerc YE; Sideris L
    World J Surg Oncol; 2014 Nov; 12():332. PubMed ID: 25380618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of aggressive histology and location of primary tumor on the efficacy of surgical therapy for peritoneal carcinomatosis of colorectal origin.
    Winer J; Zenati M; Ramalingam L; Jones H; Zureikat A; Holtzman M; Lee K; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2014 May; 21(5):1456-62. PubMed ID: 24201745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
    Ihemelandu C; Mavros MN; Sugarbaker P
    Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.